These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12668184)

  • 21. Consensus statement on the bio-safety of urinary-derived gonadotrophins with respect to Creutzfeldt-Jakob disease.
    Balen AH; Lumholtz IB
    Hum Reprod; 2005 Nov; 20(11):2994-9. PubMed ID: 16055457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A practical approach to avoiding iatrogenic Creutzfeldt-Jakob disease (CJD) from invasive instruments.
    Brown P; Farrell M
    Infect Control Hosp Epidemiol; 2015 Jul; 36(7):844-8. PubMed ID: 25850546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The French surveillance network of Creutzfeldt-Jakob disease. Epidemiological data in France and worldwide.
    Brandel JP; Peckeu L; Haïk S
    Transfus Clin Biol; 2013 Sep; 20(4):395-7. PubMed ID: 23587616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevention of prion disease transmission].
    Kishida H; Kuroiwa Y
    Nihon Rinsho; 2007 Aug; 65(8):1454-9. PubMed ID: 17695283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inactivation of BSE infectivity on chips of bone by autoclaving during the manufacture of gelatine.
    Grobben AH; Steele PJ; Somerville RA; Taylor DM
    Vet Rec; 2006 Jan; 158(3):94-6. PubMed ID: 16428664
    [No Abstract]   [Full Text] [Related]  

  • 26. Managing the risk of iatrogenic transmission of Creutzfeldt-Jakob disease in the UK.
    Hall V; Brookes D; Nacul L; Gill ON; Connor N;
    J Hosp Infect; 2014 Sep; 88(1):22-7. PubMed ID: 25082752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New thoughts on CJD, surgical instruments and disease transmission.
    Williams D
    Med Device Technol; 2006; 17(1):7-8. PubMed ID: 16483102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transmissible spongiform encephalopathies (TSE): minimizing the risk of transmission by biological/biopharmaceutical products: an industry perspective.
    Kozak RW; Golker CF; Stadler P
    Dev Biol Stand; 1996; 88():257-64. PubMed ID: 9119148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transmission of BSE by blood transfusion in sheep.
    Houston F; Foster JD; Chong A; Hunter N; Bostock CJ
    Lancet; 2000 Sep; 356(9234):999-1000. PubMed ID: 11041403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inactivation of the BSE agent by the heat and pressure process for manufacturing gelatine.
    Grobben AH; Steele PJ; Somerville RA; Taylor DM; Schreuder BE
    Vet Rec; 2005 Sep; 157(10):277-81. PubMed ID: 16157568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prions: properties, occurrence, modes of transmission and relevance for blood transfusion and blood derivatives.
    Yap PL; Leaver HA; Gillon J
    Vox Sang; 1998; 74 Suppl 2():131-4. PubMed ID: 9704435
    [No Abstract]   [Full Text] [Related]  

  • 32. An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products.
    Turner ML; Ludlam CA
    Br J Haematol; 2009 Jan; 144(1):14-23. PubMed ID: 18950452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Universal white blood cell reduction in Europe: has transmission of variant Creutzfeldt-Jakob disease been prevented?
    Vamvakas EC
    Transfus Med Rev; 2011 Apr; 25(2):133-44. PubMed ID: 21345641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of variant Creutzfeldt-Jakob disease for safety of treatment with blood components: screening of lymphatic tissue is a potential tool for risk assessment.
    Sachse C; Groschup MH; Warzok R; Greinacher A
    Eur J Haematol; 2003 Jan; 70(1):11-6. PubMed ID: 12631254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The modern landscape of transfusion-related iatrogenic Creutzfeldt-Jakob disease and blood screening tests.
    Brown P; Cervenakova L
    Curr Opin Hematol; 2004 Sep; 11(5):351-6. PubMed ID: 15666660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Removal of TSE agent from plasma products manufactured in the United Kingdom.
    Roberts PL; Dalton J; Evans D; Harrison P; Li Z; Ternouth K; Thirunavukkarasu V; Bulmer M; Fernando S; McLeod N
    Vox Sang; 2013 May; 104(4):299-308. PubMed ID: 23170907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mad cows and Englishmen: an update on blood and vCJD.
    Prowse CV; MacGregor IR
    Vox Sang; 2002 Aug; 83 Suppl 1():341-9. PubMed ID: 12617166
    [No Abstract]   [Full Text] [Related]  

  • 38. [Transmissible spongiform encephalopathies: Creutzfeldt-Jakob disease].
    Rabenau HF; Preiser W; Doerr HW
    Chirurg; 1998 May; 69(5):511-21. PubMed ID: 9653555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New variant CJD-BSE (mad cow disease). The need for disposable ENT instruments.
    Bingham B
    Int J Pediatr Otorhinolaryngol; 2002 Feb; 62(3):203-6. PubMed ID: 11852121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human prion diseases: surgical lessons learned from iatrogenic prion transmission.
    Bonda DJ; Manjila S; Mehndiratta P; Khan F; Miller BR; Onwuzulike K; Puoti G; Cohen ML; Schonberger LB; Cali I
    Neurosurg Focus; 2016 Jul; 41(1):E10. PubMed ID: 27364252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.